Total Equity - Genovis AB (STO:GENO) - Alpha Spread
G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 22.75 SEK 0.22%
Market Cap: 1.5B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genovis AB
Total Equity Peer Comparison

Comparables:
ALIF B
BICO
BIOT
MCAP
M
MAGLE

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Total Equity
kr207.6m
CAGR 3-Years
32%
CAGR 5-Years
48%
CAGR 10-Years
22%
AddLife AB
STO:ALIF B
Total Equity
kr5B
CAGR 3-Years
38%
CAGR 5-Years
40%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Total Equity
kr3.1B
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Total Equity
kr3.8B
CAGR 3-Years
55%
CAGR 5-Years
37%
CAGR 10-Years
23%
MedCap AB (publ)
STO:MCAP
Total Equity
kr1.1B
CAGR 3-Years
23%
CAGR 5-Years
30%
CAGR 10-Years
16%
M
Magle Chemoswed Holding AB
STO:MAGLE
Total Equity
kr158.2m
CAGR 3-Years
11%
CAGR 5-Years
26%
CAGR 10-Years
N/A

See Also

What is Genovis AB's Total Equity?
Total Equity
207.6m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Total Equity amounts to 207.6m SEK.

What is Genovis AB's Total Equity growth rate?
Total Equity CAGR 10Y
22%

Over the last year, the Total Equity growth was 11%. The average annual Total Equity growth rates for Genovis AB have been 32% over the past three years , 48% over the past five years , and 22% over the past ten years .

Back to Top